Calendar Provectus Biopharmaceuticals, Inc.

Equities

PVCT

US74373P1084

Market Closed - OTC Markets 15:57:37 2024-05-10 EDT 5-day change 1st Jan Change
0.1943 USD -0.82% Intraday chart for Provectus Biopharmaceuticals, Inc. +0.62% +102.40%

Chart calendar Provectus Biopharmaceuticals, Inc.

de.QbD9LneMBeK25ka_3Ep8RvYhyajnxG8aXbh1AIdUy-o.MvSHZzXGcNrMjCCO7iIzD5Nghv-oqhZyPNkCb8kYmYMCw7BiJr1kjvmNMQ~6b144f972ed94eda5d846a1472a4c151

Upcoming events on Provectus Biopharmaceuticals, Inc.

2024-05-14 Society for Investigative Dermatology Meeting

Past events on Provectus Biopharmaceuticals, Inc.

2024-04-04 American Association for Cancer Research Meeting
2024-02-22 15:00 Business Update Call
2023-11-05 Society for Melanoma Research Congress - Combination PV-10 autolytic immunotherapy
2023-11-05 Society for Melanoma Research Congress - Percutaneous autolytic immunotherapy
2023-10-31 Society for Immunotherapy of Cancer Meeting
2022-11-30 Melanoma Bridge Conference
2022-06-22 16:00 Annual Genral Meeting
2022-06-16 International Society of Ocular Oncology Congress
2022-06-06 14:15 American Society of Clinical Oncology Meeting - Abstract No 9543
2022-04-07 American Association of Cancer Research Meeting - Abstract No 2720
2022-03-09 European Neuroendocrine Tumor Society Conference - Abstract No: 3455, I25
2021-10-27 Society for Melanoma Research Meeting - Cutaneous Melanoma
2021-10-27 Society for Melanoma Research Congress - Checkpoint Blockade
2021-09-15 ESMO Congress Conference - Abstract No - 4354
2021-06-23 16:00 Annual Genral Meeting
2020-11-08 Society of Immunotherapy of Cancer Meeting - Abstract Number : 585
2020-09-18 European Society for Medical Oncology Virtual Congress - Poster No -4397
2020-09-18 European Society for Medical Oncology Virtual Congress - Poster No -4281
2020-06-21 American Association for Cancer Research Virtual Meeting - Abstract number: 5393
2020-05-28 American Society of Clinical Oncology Virtual Annual Meeting - Abstract No - 1
  1. Stock Market
  2. Equities
  3. PVCT Stock
  4. Calendar Provectus Biopharmaceuticals, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW